Home   >    Proteins   >   Growth Factors

4-1BB Receptor (TNFRSF9)

Recombinant Human 4-1BB Receptor (TNFRSF9) was expressed in E. coli cells.
Catalog No. F802-40N


For enquiry on all Growth Factors email us at orders@signalchem.com


Catalog No. Pack Size Price (USD)
F802-40N-20 20 ug $185
F802-40N-1000 1 mg $2850
F802-40N-BULK BULK Contact Us  


Overview:

4-1BB Receptor (CD137) is a member of the TNF receptor superfamily expressed on activated CD4 and CD8 T cells as well as on activated natural killer cells. The binding of 4-1BB Receptor to its TNF family ligand, 4-1BB ligand (4-1BBL) delivers a co-stimulatory signal to resting T cells leading to high level IL2 production independently of CD28 signaling. Recombinant Human 4-1BB Receptor represents the soluble, cysteine-rich TNFR-like extracellular domain of 4-1BB Receptor.


Gene Aliases:

Tumor necrosis factor receptor superfamily member 9, 41BB, 4-1BB ligand receptor, CDw137, T-cell antigen 4-1BB homolog, T-cell antigen ILA, CD137, Recombinant Human 4-1BB (TNFRSF9)


Genbank Number:



Storage, Stability and Shipping:

Recombinant 4-1BB Receptor can be stored in working aliquots at 2o - 8oC for one month, or at -20oC to -70oC for twelve months. Avoid repeated freeze/thaw cycles.


Endotoxin Level:

<1.0 EU/μg of recombinant protein as determined by the LAL method


Molecular Weight:

18.0 kDa


Reconstitution Protocol:

A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.


Sample Cell Assay Data:

The ED50 as determined by dose dependent proliferation of human megakaryocytic leukemia cell line is <0.5ng/ml.


Purity:

Recombinant Human 4-1BB Receptor (TNFRSF9) resolved on a 17% SDS-PAGE gel under reducing conditions and stained with Coomassie Brilliant Blue G-250



Product Datasheets



There are no related publications available for this product.


SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox